Cargando…
Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives
Hepatocellular carcinoma (HCC), a primary liver malignancy, is one of the deadliest cancers worldwide. Despite orthotopic liver transplantation and hepatic resection representing the principal lines of treatment for this pathology, only a minority of patients can be resected owing to cirrhosis or la...
Autores principales: | Bimonte, Sabrina, Albino, Vittorio, Piccirillo, Mauro, Nasto, Aurelio, Molino, Carlo, Palaia, Raffaele, Cascella, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387605/ https://www.ncbi.nlm.nih.gov/pubmed/30858692 http://dx.doi.org/10.2147/DDDT.S180079 |
Ejemplares similares
-
Inhibitory effect of (−)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth
por: Bimonte, Sabrina, et al.
Publicado: (2015) -
Dissecting the roles of thymoquinone on the prevention and the treatment of hepatocellular carcinoma: an overview on the current state of knowledge
por: Bimonte, Sabrina, et al.
Publicado: (2019) -
The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge
por: Bimonte, Sabrina, et al.
Publicado: (2020) -
An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma
por: Bimonte, Sabrina, et al.
Publicado: (2015) -
The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practice
por: Cascella, Marco, et al.
Publicado: (2017)